Clinical Trial Update: Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated extended-dose chloroquine for resistant falciparum malaria among Afghan refugees in Pakistan. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Falciparum | Phase 4 | Status: COMPLETED